Pharma Industry News

FDA Approves AbbVie Therapy for Adults with Advanced Parkinson’s Disease

Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.

Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]